Home > Boards > US Listed > Medical - Equipment > Pressure BioSciences Inc. (PBIO)

Global ovarian cancer diagnostics market alone is forecasted

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
budfoxfun Member Profile
Member Level 
Followed By 891
Posts 336,522
Boards Moderated 5
Alias Born 06/24/11
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2021 5:31:05 PM
Pressure Biosciences finalizes plan to acquire global eco-friendly agrochemical supplier Seeking Alpha - 4/14/2021 7:51:55 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/1/2021 10:49:37 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/16/2021 6:02:03 AM
Pressure Biosciences plans to acquire assets of global eco-friendly agrochemical supplier Seeking Alpha - 2/8/2021 9:04:13 AM
Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via InvestorsHub NewsWire - 1/20/2021 9:18:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/31/2020 9:17:28 AM
Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams InvestorsHub NewsWire - 12/17/2020 9:00:00 AM
Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum InvestorsHub NewsWire - 12/15/2020 10:19:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 5:04:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 5:02:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 5:00:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/11/2020 4:55:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2020 4:00:42 PM
Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update InvestorsHub NewsWire - 11/17/2020 11:12:11 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/16/2020 4:28:31 PM
Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update InvestorsHub NewsWire - 11/16/2020 3:20:19 PM
Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform InvestorsHub NewsWire - 11/11/2020 10:38:28 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 6:54:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 6:52:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 6:50:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 6:50:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2020 6:46:11 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/29/2020 5:23:58 PM
$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition InvestorsHub NewsWire - 6/11/2020 9:00:46 AM
budfoxfun Member Level  Monday, 10/21/19 01:48:00 PM
Re: jedijazz post# 9734
Post # of 28275 
Global ovarian cancer diagnostics market alone is forecasted to grow at a CAGR around 5.9% over the forecast time frame and reach around US $1.8 billion by 2026. New, improved methods to detect these cancers are vitally needed to support the design and development of better treatments through enhanced precision medicine. The IGCS is committed to addressing this critical issue. $PBIO Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
https://finance.yahoo.com/news/pressure-biosciences-proprietary-pct-platform-113000015.html

PBIO


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences